Carl Zeiss Meditec AG provided earnings guidance for the year 2021. For the year, the company expects revenue to reach around EUR 1.6 billion (past year: EUR 1,335.5 million). EBIT margin is projected to reach a level of approximately 20% (past year: 13.3%), with significant support from lower than usual sales and marketing expenses in the current year. The company's mid-term margin outlook remains unchanged: to generate an EBIT margin sustainably above the level of 18%.